
CSPC Innovation Pharmaceutical Co., Ltd.
- Jurisdiction
China - ISIN
CNE100003K04 (300765.SZ )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. Read full profile
Stock price
Fundamentals
- Net revenue
€247.93M - Gross margin
39.2% - EBIT
-€52.89M - EBIT margin
-21.3% - Net income
-€10.36M - Net margin
-4.2%
Statement period: - (published )
Dividends
- Last dividend amount
-
CN¥0.02 - Ex date
-
- Payment date
-